The Latin America, Middle East and Africa Transcriptomics Market would witness market growth of 11.7% CAGR during the forecast period (2021-2027).
The transcriptomics market is relatively a new industry with a lot of room for expansion. Recent technological developments have facilitated the quick adoption of technology. Transcriptomics enables the isolation of a single cell with specified traits from a heterogeneous mixture, as well as gene and protein expression analyses. Transcriptomics technology's unique ability to incorporate data from diverse substances and cells to examine cell-to-cell differentiation allows researchers to investigate mechanisms that are observable at the transcriptome level.
Evaluating the expression of an organism's genes in various tissues or environments, or at different periods, exposes characteristics of an organism's biology and how genes are regulated. It can also be utilized to infer the roles of genes that have yet to be annotated. Transcriptome analysis has aided in the knowledge of human disease by allowing researchers to investigate how gene expression changes in various organisms. Gene expression analysis in its whole allows for the observation of broad coordinated patterns that are impossible to detect with more specialized assays.
Some of the key trends of the Transcriptomics Market are an expansion in the number of biopharmaceutical companies, academic institutions, and research institutes, as well as significant investments in biomarker development and cancer research.
Given the vast regions covered by developed-world developments in molecular and omics-based technologies, their adoption and implementation in developed countries remain dubious. Ageing and population expansion, as well as increased incidence of risk factors, have made cancer a pervasive problem in African countries. In 2008, Africa had 715,000 new cancer cases and 542,000 fatalities, according to estimates. According to United Nations population predictions, Africa's population would grow by 60% overall between 2010 and 2030, and by 90% for those aged 60 and more, the age at which cancer is most common. Despite this growing burden, cancer continues to be a low priority for public health throughout Africa, with a few exceptions.
The Brazil market dominated the LAMEA Transcriptomics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $142.8 million by 2027. The Argentina market is estimated to grow at a CAGR of 12.3% during (2021 - 2027). Additionally, The UAE market would witness a CAGR of 11.4% during (2021 - 2027).
Based on Technology, the market is segmented into q PCR, Microarrays, and Sequencing Technology. Based on Application, the market is segmented into Drug Discovery, Diagnostics & Disease Profiling, and Others. Based on Component, the market is segmented into Consumables, Instruments, Software, and Services. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Transcriptomics Market is Predict to reach $9.4 Billion by 2027, at a CAGR of 7.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fluidigm Corporation, Promega Corporation, General Electric (GE) Co., Merck & Co., Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., and Qiagen N.V.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- q PCR
- Microarrays
- Sequencing Technology
By Application
- Drug Discovery
- Diagnostics & Disease Profiling
- Others
By Component
- Consumables
- Instruments
- Software
- Services
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Fluidigm Corporation
- Promega Corporation
- General Electric (GE) Co.
- Merck & Co., Inc.
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Qiagen N.V.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Transcriptomics Market, by Technology
1.4.2 LAMEA Transcriptomics Market, by Application
1.4.3 LAMEA Transcriptomics Market, by Component
1.4.4 LAMEA Transcriptomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan – 2021, Apr) Leading Players
3.3.3 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar – 2021, Nov) Leading Players
Chapter 4. LAMEA Transcriptomics Market by Technology
4.1 LAMEA q PCR Market by Country
4.2 LAMEA Microarrays Market by Country
4.3 LAMEA Sequencing Technology Market by Country
Chapter 5. LAMEA Transcriptomics Market by Application
5.1 LAMEA Drug Discovery Market by Country
5.2 LAMEA Diagnostics & Disease Profiling Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Transcriptomics Market by Component
6.1 LAMEA Consumables Market by Country
6.2 LAMEA Instruments Market by Country
6.3 LAMEA Software Market by Country
6.4 LAMEA Services Market by Country
Chapter 7. LAMEA Transcriptomics Market by Country
7.1 Brazil Transcriptomics Market
7.1.1 Brazil Transcriptomics Market by Technology
7.1.2 Brazil Transcriptomics Market by Application
7.1.3 Brazil Transcriptomics Market by Component
7.2 Argentina Transcriptomics Market
7.2.1 Argentina Transcriptomics Market by Technology
7.2.2 Argentina Transcriptomics Market by Application
7.2.3 Argentina Transcriptomics Market by Component
7.3 UAE Transcriptomics Market
7.3.1 UAE Transcriptomics Market by Technology
7.3.2 UAE Transcriptomics Market by Application
7.3.3 UAE Transcriptomics Market by Component
7.4 Saudi Arabia Transcriptomics Market
7.4.1 Saudi Arabia Transcriptomics Market by Technology
7.4.2 Saudi Arabia Transcriptomics Market by Application
7.4.3 Saudi Arabia Transcriptomics Market by Component
7.5 South Africa Transcriptomics Market
7.5.1 South Africa Transcriptomics Market by Technology
7.5.2 South Africa Transcriptomics Market by Application
7.5.3 South Africa Transcriptomics Market by Component
7.6 Nigeria Transcriptomics Market
7.6.1 Nigeria Transcriptomics Market by Technology
7.6.2 Nigeria Transcriptomics Market by Application
7.6.3 Nigeria Transcriptomics Market by Component
7.7 Rest of LAMEA Transcriptomics Market
7.7.1 Rest of LAMEA Transcriptomics Market by Technology
7.7.2 Rest of LAMEA Transcriptomics Market by Application
7.7.3 Rest of LAMEA Transcriptomics Market by Component
Chapter 8. Company Profiles
8.1 Fluidigm Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.2 Promega Corporation
8.2.1 Company Overview
8.3 General Electric (GE) Co. (GE Healthcare)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Merck & Co., Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Thermo Fisher Scientific, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 Illumina, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.5.3 Acquisition and Mergers:
8.8 Agilent Technologies, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Acquisition and Mergers:
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Qiagen N.V.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
8.10.5.3 Acquisition and Mergers:
TABLE 1 LAMEA Transcriptomics Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Transcriptomics Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Transcriptomics Market
TABLE 4 Product Launches And Product Expansions – Transcriptomics Market
TABLE 5 Acquisition and Mergers– Transcriptomics Market
TABLE 6 LAMEA Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 7 LAMEA Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 8 LAMEA q PCR Market by Country, 2017 - 2020, USD Million
TABLE 9 LAMEA q PCR Market by Country, 2021 - 2027, USD Million
TABLE 10 LAMEA Microarrays Market by Country, 2017 - 2020, USD Million
TABLE 11 LAMEA Microarrays Market by Country, 2021 - 2027, USD Million
TABLE 12 LAMEA Sequencing Technology Market by Country, 2017 - 2020, USD Million
TABLE 13 LAMEA Sequencing Technology Market by Country, 2021 - 2027, USD Million
TABLE 14 LAMEA Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 15 LAMEA Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 16 LAMEA Drug Discovery Market by Country, 2017 - 2020, USD Million
TABLE 17 LAMEA Drug Discovery Market by Country, 2021 - 2027, USD Million
TABLE 18 LAMEA Diagnostics & Disease Profiling Market by Country, 2017 - 2020, USD Million
TABLE 19 LAMEA Diagnostics & Disease Profiling Market by Country, 2021 - 2027, USD Million
TABLE 20 LAMEA Others Market by Country, 2017 - 2020, USD Million
TABLE 21 LAMEA Others Market by Country, 2021 - 2027, USD Million
TABLE 22 LAMEA Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 23 LAMEA Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 24 LAMEA CONSUMABLES MARKET by Country, 2017 - 2020, USD Million
TABLE 25 LAMEA Consumables Market by Country, 2021 - 2027, USD Million
TABLE 26 LAMEA INSTRUMENTS MARKET by Country, 2017 - 2020, USD Million
TABLE 27 LAMEA INSTRUMENTS MARKET by Country, 2021 - 2027, USD Million
TABLE 28 LAMEA SOFTWARE MARKET by Country, 2017 - 2020, USD Million
TABLE 29 LAMEA SOFTWARE MARKET by Country, 2021 - 2027, USD Million
TABLE 30 LAMEA Services Market by Country, 2017 - 2020, USD Million
TABLE 31 LAMEA Services Market by Country, 2021 - 2027, USD Million
TABLE 32 LAMEA Transcriptomics Market by Country, 2017 - 2020, USD Million
TABLE 33 LAMEA Transcriptomics Market by Country, 2021 - 2027, USD Million
TABLE 34 Brazil Transcriptomics Market, 2017 - 2020, USD Million
TABLE 35 Brazil Transcriptomics Market, 2021 - 2027, USD Million
TABLE 36 Brazil Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 37 Brazil Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 38 Brazil Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 39 Brazil Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 40 Brazil Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 41 Brazil Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 42 Argentina Transcriptomics Market, 2017 - 2020, USD Million
TABLE 43 Argentina Transcriptomics Market, 2021 - 2027, USD Million
TABLE 44 Argentina Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 45 Argentina Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 46 Argentina Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 47 Argentina Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 48 Argentina Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 49 Argentina Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 50 UAE Transcriptomics Market, 2017 - 2020, USD Million
TABLE 51 UAE Transcriptomics Market, 2021 - 2027, USD Million
TABLE 52 UAE Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 53 UAE Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 54 UAE Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 55 UAE Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 56 UAE Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 57 UAE Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 58 Saudi Arabia Transcriptomics Market, 2017 - 2020, USD Million
TABLE 59 Saudi Arabia Transcriptomics Market, 2021 - 2027, USD Million
TABLE 60 Saudi Arabia Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 61 Saudi Arabia Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 62 Saudi Arabia Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 63 Saudi Arabia Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 64 Saudi Arabia Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 65 Saudi Arabia Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 66 South Africa Transcriptomics Market, 2017 - 2020, USD Million
TABLE 67 South Africa Transcriptomics Market, 2021 - 2027, USD Million
TABLE 68 South Africa Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 69 South Africa Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 70 South Africa Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 71 South Africa Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 72 South Africa Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 73 South Africa Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 74 Nigeria Transcriptomics Market, 2017 - 2020, USD Million
TABLE 75 Nigeria Transcriptomics Market, 2021 - 2027, USD Million
TABLE 76 Nigeria Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 77 Nigeria Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 78 Nigeria Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 79 Nigeria Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 80 Nigeria Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 81 Nigeria Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 82 Rest of LAMEA Transcriptomics Market, 2017 - 2020, USD Million
TABLE 83 Rest of LAMEA Transcriptomics Market, 2021 - 2027, USD Million
TABLE 84 Rest of LAMEA Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 85 Rest of LAMEA Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 86 Rest of LAMEA Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 87 Rest of LAMEA Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 88 Rest of LAMEA Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 89 Rest of LAMEA Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 90 Key Information – Fluidigm Corporation
TABLE 91 key Information – Promega Corporation
TABLE 92 Key Information – General Electric (GE) Co.
TABLE 93 KEY INFORMATION - MERCK & CO., INC.
TABLE 94 Key Information – Thermo Fisher Scientific, Inc.
TABLE 95 key information – Illumina, Inc.
TABLE 96 Key Information – Bio-Rad Laboratories, Inc.
TABLE 97 key Information – Agilent Technologies, Inc.
TABLE 98 key information – F. Hoffmann-La Roche Ltd.
TABLE 99 Key Information – Qiagen N.V.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan – 2021, Apr) Leading Players
FIG 5 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar – 2021, Nov) Leading Players
FIG 6 Swot analysis: thermo fisher scientific, inc.
FIG 7 Recent strategies and developments: Bio-Rad Laboratories, Inc.
FIG 8 Recent strategies and developments: Qiagen N.V.